Skip to main content
  • Paclitaxel Controversy Casts Long Shadow on CRT DCB Session

    The still-simmering controversy surrounding the efficacy and safety of paclitaxel-coated devices for the periphery artery highlighted a focused session Saturday at CRT Virtual 2021.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details